Alexander White MD

Family Medicine•Daytona Beach, FL

Owner/Medical Director Progressive Medical Research

Join to View Full Profile

303 N Clyde Morris Blvd# HalifaxDaytona Beach, FL 32114
Phone+1 386-254-2285
Fax+1 386-425-1304

Education & Training

Halifax Medical CenterResidency, Family Medicine, 1991 - 1994
University of South Florida College of MedicineClass of 1991

Certifications & Licensure

FL State Medical License 1993 - 2027

Clinical Trials

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01
Completed
Phase 2
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Start of enrollment: 2017 Jan 31
Completed
Phase 1
Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03
COMPLETED
PHASE3
Roles: Principal Investigator, Contact
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy Start of enrollment: 2019 Sep 20
Active, not recruiting
Phase 3
Roles: Contact
A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects with Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen Start of enrollment: 2023 Mar 13
COMPLETED
PHASE2
Roles: Contact
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects with Hypertension Start of enrollment: 2023 Jul 14
ENROLLING_BY_INVITATION
PHASE3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

26 citations
Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynureni...
Mark S. Wallace, Alexander White, Kathy A Grako, Randal Lane, Allen Jo Cato
Scandinavian Journal of Pain. 2017-10-01
188 citations
Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized,...
James G. Krueger, Laura K. Ferris, Alan Menter, Frank Wagner, Alexander White
The Journal of Allergy and Clinical Immunology. 2015-07-01